Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Walgreens’ head of pharmacy to step down

Kermit Crawford plans to retire

PMCPA looks to app to simplify the APBI Code of Practice

Code regulator takes 'digitally-led' approach in partnership with The Earthworks

- PMLiVE

J&J’s Imbruvica wins new cancer indication

FDA backs drug’s use in chronic lymphocytic leukaemia patients with genetic mutation

Novartis building

Novartis’ glaucoma combo cleared in Europe

Simbrinza approved to treat eye condition

- PMLiVE

Reckitt Benckiser confirms pharma spin-off plans

Will separate prescription and consumer health businesses

- PMLiVE

Amgen launches bowel cancer web portal in Spain

Aims to help healthcare professionals understand about personalised medicine

- PMLiVE

Peix appoints online marketing manager

Marie Kruger joins German agency

- PMLiVE

This month in 1989: the creation of Bristol-Myers Squibb

The emergence of a company with a new focus on healthcare and research

- PMLiVE

Cipla names Adil Zainulbhai to board

He has experience at consulting firm McKinsey & Company

- PMLiVE

AZ signs two companion diagnostic deals

Will help identify patients suitable for treatment with lung cancer drugs

Biogen Idec building

Plegridy approval underlines Biogen Idec’s dominance in MS

And Tecfidera boosts pharma company’s second quarter financial results

- PMLiVE

Two blood cancer drugs among CHMP recommendations

Five new drugs, including Janssen’s Imbruvica and Gilead’s Zydelig, backed for use in Europe

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links